Amneal Pharmaceuticals, LLC is recalling 12,624 bottles of Methotrexate (2.5 mg) tablets because some bottles may contain a different medication called Fludrocortisone Acetate (0.1 mg). The recall involves 100-count bottles from a single lot (BB29124) with an expiration date of February 2026. Methotrexate is used to treat certain cancers and autoimmune conditions, while Fludrocortisone is a corticosteroid; finding the wrong pill in your bottle could lead to taking the incorrect medication or missing a required dose.
If a patient accidentally takes Fludrocortisone instead of Methotrexate, they may experience side effects from the corticosteroid while their underlying condition remains undertreated. No incidents or injuries have been reported to date in connection with this issue.
You have 2 options:
Distributed By Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.